Enhanced Linkage to HIV Care Following Home-Based HIV Testing in Rural Uganda

Sponsor
Susan M Kiene (Other)
Overall Status
Completed
CT.gov ID
NCT02545673
Collaborator
Makerere University (Other), University of Connecticut (Other), Harvard School of Public Health (HSPH) (Other), National Institute of Mental Health (NIMH) (NIH)
567
1
2
71.2
8

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of a linkage to care intervention at achieving HIV viral suppression and intermediate outcomes of linkage/time to care, time to /receipt of opportunistic infection prophylaxis, and antiretroviral therapy (ART) among people testing HIV positive during home-based HIV counseling and testing (HBHCT) in rural Uganda.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Enhanced linkage to care
  • Behavioral: Standard-of-care plus
N/A

Detailed Description

Throughout sub-Saharan Africa there is a pressing need to facilitate early and easier entry into HIV care and treatment; up to two-thirds of patients are lost to follow up between testing HIV positive and initiation of antiretroviral (ARV) treatment. Home-based HIV testing and counseling (HBHCT), which identifies those who are HIV positive at earlier disease stages than other testing approaches, is becoming a large component of many sub-Saharan African countries' HIV prevention programs, including Uganda's. Paper-based referral to care, sometimes adding follow-up home visits, is the most common linkage-to-care approach with HBHCT. Linkage to care may be challenging with HBHCT since the testing occurs in the home at a distance from a health facility. The investigators propose to test an intervention which enhances a linkage to care intervention tested in an urban Ugandan provider-initiated HIV testing setting and found to improve linkage to care. The aims of the project are: (1) In a cluster randomized trial compare the effectiveness of the enhanced linkage to care intervention vs. standard-of-care (paper based referrals) at achieving HIV viral suppression and intermediate outcomes of linkage to care, receipt of opportunistic infection prophylaxis, and ART initiation among those eligible for antiretroviral therapy (ART). (2) Using the standard-of-care group as a natural history control, collect longitudinal data on barriers to and facilitators of linkage to and retention in care and treatment and HIV viral suppression. (3) Estimate the cost-effectiveness of the intervention, as compared to standard-of-care, in terms of major study outcomes.

Participation in the full study will last 12 months. All participants will first undergo HBHCT, viral load and CD4 testing, and complete a brief questionnaire. Participants will then be randomly assigned to one of two study arms: the enhanced linkage to care intervention arm or the standard-of-care control arm. Participants in both study arms will participate in interviewer administered questionnaires at 6 months and 12 months follow-up, viral load and CD4 testing at 12 month follow-up, and will permit the research team to access their medical records to extract information about their health status and linkage to care. Participants in the intervention arm will also receive a series of counseling sessions with an HIV counselor taking place at the participant's home, clinic, and over the phone. These sessions will last approximately 30 minutes, and consist of counseling to help clients identify and reduce barriers to engagement in care, assistance disclosing and identifying a treatment supporter, and stigma reduction through increasing social support.

Study Design

Study Type:
Interventional
Actual Enrollment :
567 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Enhanced Linkage to HIV Care Following Home-Based HIV Testing in Rural Uganda
Actual Study Start Date :
Nov 24, 2015
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Oct 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Enhanced Linkage

Participants will receive the enhanced linkage to care Intervention. Behavioral: Enhanced linkage to care Intervention Multiple sessions will focus on providing orientation to the HIV care system, counseling to help clients identify and reduce barriers to engagement in care, assistance disclosing and identifying a treatment supporter, and stigma reduction through increasing social support. The approach is guided by the HIV Stigma Framework.

Behavioral: Enhanced linkage to care

Active Comparator: Standard-of-care plus

Behavioral: Participants will receive the standard-of-care (paper-based referrals) plus return of CD4 test results to their home.

Behavioral: Standard-of-care plus

Outcome Measures

Primary Outcome Measures

  1. HIV Viral load suppression [12 months follow up]

    defined as HIV RNA <20 cells/ml) collected via venous blood draw

Secondary Outcome Measures

  1. Linkage to HIV care [6 and 12 months follow up]

    Enrollment in an HIV clinic with a 2nd clinic visit

  2. Time to HIV care [6 and 12 months follow up]

    Time from HIV testing to enrollment in an HIV clinic

  3. Receipt of co-trimoxazole [6 and 12 months follow up]

    The percentage of participants who received co-trimoxazole

  4. Time to receipt of co-trimozazole [6 and 12 months follow up]

    Time to receipt of co-trimoxazole

  5. Receipt of ART [6 and 12 months follow up]

    Percentage of eligible participants receiving ART

  6. Time to receipt of ART [6 and 12 months follow up]

    Time from HIV testing to receipt of ART

  7. Short-term retention in care: Missed visits [6 and 12 months follow up]

    Missed visit count: number of missed visits accrued (count measure) based on scheduled visits determined by Ministry of Health clinical guidelines

  8. Short-term retention in care: Proportion of kept visits/scheduled visits [6 and 12 months follow up]

    Proportion of kept visits/scheduled visits (kept + missed visits)

  9. Short-term retention in care: 4 month visit constancy [6 and 12 months follow up]

    4-month constancy 4 month visit constancy: number of 4-month intervals with at least 1 kept visit

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion/Exclusion for home-based HIV counseling and testing and brief baseline questionnaire:

Inclusion Criteria:

• 18-59 years of age or an emancipated minor

Exclusion Criteria:
  • not a resident of the household

  • Does not speak Luganda or English

Inclusion/Exclusion for the Intervention Study:
Inclusion criteria:
  • participated in the baseline interview and home-based HIV counseling and testing,

  • newly diagnosed HIV positive in the home-based HIV counseling and testing

Exclusion criteria:

• Other household members also newly diagnosed as HIV positive. Only one newly diagnosed HIV positive person per household will be included

Contacts and Locations

Locations

Site City State Country Postal Code
1 Butambala, Mpigi, Mityana, Gomba Districts Gombe Uganda

Sponsors and Collaborators

  • Susan M Kiene
  • Makerere University
  • University of Connecticut
  • Harvard School of Public Health (HSPH)
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Susan M. Kiene, PhD, San Diego State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susan M Kiene, Professor, San Diego State University
ClinicalTrials.gov Identifier:
NCT02545673
Other Study ID Numbers:
  • UG2015_01
  • R01MH106391
First Posted:
Sep 10, 2015
Last Update Posted:
Dec 7, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Susan M Kiene, Professor, San Diego State University

Study Results

No Results Posted as of Dec 7, 2021